Tokyo, Japan · Founded 2009 · Privately Held (backing)
Developer of a medical device incubator and accelerator intended to support and advance medical start-up companies. Neuroceuticals is based in Tokyo, Japan and was founded in 2009. Its last reported valuation was $13.1 million in Nov 2018. It has raised $4.6 million.
Last reported valuation
$13.1M
Oct 2026
Priced at
—
Total raised
$4.6M
Last round
—
Cap table — not yet on record
Neuroceuticals's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Neuroceuticals with a free account
·Watch Neuroceuticals: the Monday email on marks, rounds and moves
